Cite
MLA Citation
Ad A van Bodegraven et al.. “Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation.” Gut, vol. 63, no. 9, 2014, pp. 1424–1430. http://access.bl.uk/ark:/81055/vdc_100135139778.0x000042